Efficacy and Safety of Oritavancin Relative to Vancomycin for Patients with Acute Bacterial Skin and Skin Structure Infections (ABSSSI) in the Outpatient Setting: Results From the SOLO Clinical Trials

BACKGROUND: The objective of this analysis was to evaluate the efficacy and safety of oritavancin compared with vancomycin for patients with acute bacterial skin and skin structure infections (ABSSSIs) who received treatment in the outpatient setting in the Phase 3 SOLO clinical trials. METHODS: SOL...

Descripción completa

Detalles Bibliográficos
Autores principales: Lodise, Thomas P., Redell, Mark, Armstrong, Shannon O., Sulham, Katherine A., Corey, G. Ralph
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2017
Materias:
Major Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5414048/
https://www.ncbi.nlm.nih.gov/pubmed/28480266
http://dx.doi.org/10.1093/ofid/ofw274

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5414048/
https://www.ncbi.nlm.nih.gov/pubmed/28480266
http://dx.doi.org/10.1093/ofid/ofw274

Ejemplares similares